Annual CAPEX
$498.00 M
-$28.00 M-5.32%
December 31, 2024
Summary
- As of February 12, 2025, TEVA annual capital expenditures is $498.00 million, with the most recent change of -$28.00 million (-5.32%) on December 31, 2024.
- During the last 3 years, TEVA annual CAPEX has fallen by -$64.00 million (-11.39%).
- TEVA annual CAPEX is now -54.89% below its all-time high of $1.10 billion, reached on December 31, 2012.
Performance
TEVA CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
$129.00 M
-$19.00 M-12.84%
December 31, 2024
Summary
- As of February 12, 2025, TEVA quarterly capital expenditures is $129.00 million, with the most recent change of -$19.00 million (-12.84%) on December 31, 2024.
- Over the past year, TEVA quarterly CAPEX has increased by +$5.00 million (+4.03%).
- TEVA quarterly CAPEX is now -61.26% below its all-time high of $333.00 million, reached on December 31, 2016.
Performance
TEVA Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CAPEX
$498.00 M
+$10.00 M+2.05%
December 31, 2024
Summary
- As of February 12, 2025, TEVA TTM capital expenditures is $498.00 million, with the most recent change of +$10.00 million (+2.05%) on December 31, 2024.
- Over the past year, TEVA TTM CAPEX has dropped by -$13.00 million (-2.54%).
- TEVA TTM CAPEX is now -55.58% below its all-time high of $1.12 billion, reached on June 30, 2012.
Performance
TEVA TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TEVA CAPEX Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -5.3% | +4.0% | -2.5% |
3 y3 years | -11.4% | +1.6% | -14.6% |
5 y5 years | -5.1% | -26.7% | -13.8% |
TEVA CAPEX Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -11.4% | at low | -17.8% | +33.0% | -14.6% | +2.0% |
5 y | 5-year | -13.8% | at low | -26.7% | +33.0% | -17.0% | +2.0% |
alltime | all time | -54.9% | +2133.2% | -61.3% | +451.7% | -55.6% | +2029.8% |
Teva Pharmaceutical Industries Limited CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | $498.00 M(-5.3%) | $129.00 M(-12.8%) | $498.00 M(+2.0%) |
Sep 2024 | - | $148.00 M(+52.6%) | $488.00 M(-0.2%) |
Jun 2024 | - | $97.00 M(-21.8%) | $489.00 M(-4.3%) |
Mar 2024 | - | $124.00 M(+4.2%) | $511.00 M(-2.9%) |
Dec 2023 | $526.00 M(-4.0%) | $119.00 M(-20.1%) | $526.00 M(-4.2%) |
Sep 2023 | - | $149.00 M(+25.2%) | $549.00 M(+5.2%) |
Jun 2023 | - | $119.00 M(-14.4%) | $522.00 M(-1.5%) |
Mar 2023 | - | $139.00 M(-2.1%) | $530.00 M(-3.3%) |
Dec 2022 | $548.00 M(-2.5%) | $142.00 M(+16.4%) | $548.00 M(-2.0%) |
Sep 2022 | - | $122.00 M(-3.9%) | $559.00 M(-4.1%) |
Jun 2022 | - | $127.00 M(-19.1%) | $583.00 M(+2.5%) |
Mar 2022 | - | $157.00 M(+2.6%) | $569.00 M(+1.2%) |
Dec 2021 | $562.00 M(-2.8%) | $153.00 M(+4.8%) | $562.00 M(-3.9%) |
Sep 2021 | - | $146.00 M(+29.2%) | $585.00 M(+0.5%) |
Jun 2021 | - | $113.00 M(-24.7%) | $582.00 M(-3.0%) |
Mar 2021 | - | $150.00 M(-14.8%) | $600.00 M(+3.8%) |
Dec 2020 | $578.00 M(+10.1%) | $176.00 M(+23.1%) | $578.00 M(+10.9%) |
Sep 2020 | - | $143.00 M(+9.2%) | $521.00 M(-4.8%) |
Jun 2020 | - | $131.00 M(+2.3%) | $547.00 M(+3.6%) |
Mar 2020 | - | $128.00 M(+7.6%) | $528.00 M(+0.6%) |
Dec 2019 | $525.00 M(-19.4%) | $119.00 M(-29.6%) | $525.00 M(-15.2%) |
Sep 2019 | - | $169.00 M(+50.9%) | $619.00 M(+5.1%) |
Jun 2019 | - | $112.00 M(-10.4%) | $589.00 M(-3.9%) |
Mar 2019 | - | $125.00 M(-41.3%) | $613.00 M(-5.8%) |
Dec 2018 | $651.00 M(-25.5%) | $213.00 M(+53.2%) | $651.00 M(-7.7%) |
Sep 2018 | - | $139.00 M(+2.2%) | $705.00 M(-9.4%) |
Jun 2018 | - | $136.00 M(-16.6%) | $778.00 M(-6.8%) |
Mar 2018 | - | $163.00 M(-39.0%) | $835.00 M(-4.5%) |
Dec 2017 | $874.00 M(-3.0%) | $267.00 M(+25.9%) | $874.00 M(-7.0%) |
Sep 2017 | - | $212.00 M(+9.8%) | $940.00 M(-0.9%) |
Jun 2017 | - | $193.00 M(-4.5%) | $949.00 M(+1.9%) |
Mar 2017 | - | $202.00 M(-39.3%) | $931.00 M(+3.3%) |
Dec 2016 | $901.00 M(+16.7%) | $333.00 M(+50.7%) | $901.00 M(+10.4%) |
Sep 2016 | - | $221.00 M(+26.3%) | $816.00 M(+6.7%) |
Jun 2016 | - | $175.00 M(+1.7%) | $765.00 M(+0.8%) |
Mar 2016 | - | $172.00 M(-30.6%) | $759.00 M(-1.7%) |
Dec 2015 | $772.00 M(-16.9%) | $248.00 M(+45.9%) | $772.00 M(-6.3%) |
Sep 2015 | - | $170.00 M(+0.6%) | $824.00 M(-4.8%) |
Jun 2015 | - | $169.00 M(-8.6%) | $866.00 M(-2.6%) |
Mar 2015 | - | $185.00 M(-38.3%) | $889.00 M(-4.3%) |
Dec 2014 | $929.00 M(-9.9%) | $300.00 M(+41.5%) | $929.00 M(-1.5%) |
Sep 2014 | - | $212.00 M(+10.4%) | $943.00 M(-1.7%) |
Jun 2014 | - | $192.00 M(-14.7%) | $959.00 M(-3.3%) |
Mar 2014 | - | $225.00 M(-28.3%) | $992.00 M(-3.8%) |
Dec 2013 | $1.03 B(-6.6%) | $314.00 M(+37.7%) | $1.03 B(-1.2%) |
Sep 2013 | - | $228.00 M(+1.3%) | $1.04 B(-2.0%) |
Jun 2013 | - | $225.00 M(-14.8%) | $1.06 B(-2.7%) |
Mar 2013 | - | $264.00 M(-19.3%) | $1.09 B(-0.9%) |
Dec 2012 | $1.10 B(+4.8%) | $327.00 M(+31.3%) | $1.10 B(+0.9%) |
Sep 2012 | - | $249.00 M(-2.0%) | $1.09 B(-2.4%) |
Jun 2012 | - | $254.00 M(-7.3%) | $1.12 B(+2.6%) |
Mar 2012 | - | $274.00 M(-13.6%) | $1.09 B(+3.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2011 | $1.05 B(+48.3%) | $317.00 M(+14.9%) | $1.05 B(+8.6%) |
Sep 2011 | - | $276.00 M(+22.1%) | $970.00 M(+11.6%) |
Jun 2011 | - | $226.00 M(-3.4%) | $869.00 M(+11.6%) |
Mar 2011 | - | $234.00 M(0.0%) | $779.00 M(+9.7%) |
Dec 2010 | $710.00 M(-1.3%) | $234.00 M(+33.7%) | $710.00 M(+3.2%) |
Sep 2010 | - | $175.00 M(+28.7%) | $688.00 M(-3.0%) |
Jun 2010 | - | $136.00 M(-17.6%) | $709.00 M(-19.8%) |
Mar 2010 | - | $165.00 M(-22.2%) | $884.00 M(+22.9%) |
Dec 2009 | $719.00 M(+5.6%) | $212.00 M(+8.2%) | $719.00 M(+4.5%) |
Sep 2009 | - | $196.00 M(-37.0%) | $688.00 M(+2.7%) |
Jun 2009 | - | $311.00 M(+71.8%) | $670.00 M(-1.6%) |
Dec 2008 | $681.00 M(+25.6%) | $181.00 M(+1.7%) | $681.00 M(+5.1%) |
Sep 2008 | - | $178.00 M(-1.1%) | $648.00 M(+8.4%) |
Jun 2008 | - | $180.00 M(+26.8%) | $598.00 M(+13.3%) |
Mar 2008 | - | $142.00 M(-4.1%) | $528.00 M(-2.6%) |
Dec 2007 | $542.00 M(+39.0%) | $148.00 M(+15.6%) | $542.00 M(+5.9%) |
Sep 2007 | - | $128.00 M(+16.4%) | $511.90 M(+6.3%) |
Jun 2007 | - | $110.00 M(-29.5%) | $481.60 M(+1.6%) |
Mar 2007 | - | $156.00 M(+32.3%) | $474.00 M(+21.5%) |
Dec 2006 | $390.00 M(+25.8%) | $117.90 M(+20.7%) | $390.00 M(+9.8%) |
Sep 2006 | - | $97.70 M(-4.6%) | $355.30 M(+4.3%) |
Jun 2006 | - | $102.40 M(+42.2%) | $340.70 M(+11.8%) |
Mar 2006 | - | $72.00 M(-13.5%) | $304.70 M(-1.7%) |
Dec 2005 | $310.00 M(-0.3%) | $83.20 M(+0.1%) | $310.00 M(-5.0%) |
Sep 2005 | - | $83.10 M(+25.2%) | $326.20 M(+2.5%) |
Jun 2005 | - | $66.40 M(-14.1%) | $318.10 M(-1.9%) |
Mar 2005 | - | $77.30 M(-22.2%) | $324.20 M(+4.2%) |
Dec 2004 | $311.00 M(+49.9%) | $99.40 M(+32.5%) | $311.00 M(+12.4%) |
Sep 2004 | - | $75.00 M(+3.4%) | $276.60 M(+6.6%) |
Jun 2004 | - | $72.50 M(+13.1%) | $259.50 M(+10.6%) |
Mar 2004 | - | $64.10 M(-1.4%) | $234.70 M(+13.1%) |
Dec 2003 | $207.50 M(+29.4%) | $65.00 M(+12.3%) | $207.50 M(+7.5%) |
Sep 2003 | - | $57.90 M(+21.4%) | $193.00 M(+15.1%) |
Jun 2003 | - | $47.70 M(+29.3%) | $167.70 M(-0.4%) |
Mar 2003 | - | $36.90 M(-26.9%) | $168.30 M(+4.9%) |
Dec 2002 | $160.40 M(+19.6%) | $50.50 M(+54.9%) | $160.40 M(+4.9%) |
Sep 2002 | - | $32.60 M(-32.5%) | $152.97 M(+0.9%) |
Jun 2002 | - | $48.30 M(+66.6%) | $151.65 M(+8.6%) |
Mar 2002 | - | $29.00 M(-32.7%) | $139.68 M(+4.2%) |
Dec 2001 | $134.07 M(+49.9%) | $43.07 M(+37.7%) | $134.07 M(+47.3%) |
Sep 2001 | - | $31.28 M(-13.9%) | $91.00 M(+52.4%) |
Jun 2001 | - | $36.34 M(+55.4%) | $59.72 M(+155.4%) |
Mar 2001 | - | $23.38 M | $23.38 M |
Dec 2000 | $89.42 M(+33.3%) | - | - |
Dec 1999 | $67.07 M(+22.0%) | - | - |
Dec 1998 | $54.98 M(-13.3%) | - | - |
Dec 1997 | $63.40 M(-53.1%) | - | - |
Dec 1996 | $135.30 M(+11.2%) | - | - |
Dec 1995 | $121.70 M(+35.8%) | - | - |
Dec 1994 | $89.60 M(+97.8%) | - | - |
Dec 1993 | $45.30 M(-7.0%) | - | - |
Dec 1992 | $48.70 M(+118.4%) | - | - |
Dec 1991 | $22.30 M | - | - |
FAQ
- What is Teva Pharmaceutical Industries Limited annual capital expenditures?
- What is the all time high annual CAPEX for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual CAPEX year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly CAPEX year-on-year change?
- What is Teva Pharmaceutical Industries Limited TTM capital expenditures?
- What is the all time high TTM CAPEX for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited TTM CAPEX year-on-year change?
What is Teva Pharmaceutical Industries Limited annual capital expenditures?
The current annual CAPEX of TEVA is $498.00 M
What is the all time high annual CAPEX for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual capital expenditures is $1.10 B
What is Teva Pharmaceutical Industries Limited annual CAPEX year-on-year change?
Over the past year, TEVA annual capital expenditures has changed by -$28.00 M (-5.32%)
What is Teva Pharmaceutical Industries Limited quarterly capital expenditures?
The current quarterly CAPEX of TEVA is $129.00 M
What is the all time high quarterly CAPEX for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly capital expenditures is $333.00 M
What is Teva Pharmaceutical Industries Limited quarterly CAPEX year-on-year change?
Over the past year, TEVA quarterly capital expenditures has changed by +$5.00 M (+4.03%)
What is Teva Pharmaceutical Industries Limited TTM capital expenditures?
The current TTM CAPEX of TEVA is $498.00 M
What is the all time high TTM CAPEX for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high TTM capital expenditures is $1.12 B
What is Teva Pharmaceutical Industries Limited TTM CAPEX year-on-year change?
Over the past year, TEVA TTM capital expenditures has changed by -$13.00 M (-2.54%)